Advertisement

Relation of C-Reactive Protein to Abdominal Adiposity

      Inflammation is a crucial element in the development of cardiovascular disease. Serum measurements of inflammation through high-sensitivity C-reactive protein (hsCRP) can lead to improved risk stratification of patients for risk for hard cardiovascular events. There is evidence that anthropomorphic measurements of obesity are important determinants of systemic inflammation. Online databases (e.g., PubMed and Medline) were searched for original research reports published in English from June 1990 to June 2009 examining the relations between hsCRP; anthropomorphic measurements of obesity including body mass index, waist-to-hip ratio, waist circumference, and visceral adiposity; and cardiovascular disease. When possible, correlation coefficients were used to compare data among studies. Measurements of abdominal obesity are associated with systemic inflammation as measured by hsCRP (r = 0.40 to 0.61). The association between hsCRP and abdominal adiposity persists when taking into account body mass index. Elevation of hsCRP might be reversible with weight loss and exercise. In conclusion, clinical measurements of abdominal adiposity readily provide data elucidating the systemic inflammatory state of patients and can help guide intensity of lifestyle modifications, thus leading to reduction of this inflammation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Verma S.
        • Szmitko P.E.
        • Ridker P.M.
        C-reactive protein comes of age.
        Nat Clin Pract Cardiovasc Med. 2005; 2: 29-36
        • Downs J.R.
        • Clearfield M.
        • Weis S.
        • Whitney E.
        • Shapiro D.R.
        • Beere P.A.
        • Langendorfer A.
        • Stein E.A.
        • Kruyer W.
        • Gotto Jr, A.M.
        Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS.
        JAMA. 1998; 279: 1615-1622
        • Devaraj S.
        • Swarbrick M.M.
        • Singh U.
        • Adams-Huet B.
        • Havel P.J.
        • Jialal I.
        CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers.
        Am J Clin Pathol. 2008; 129: 815-822
        • Ridker P.M.
        • Rifai N.
        • Clearfield M.
        • Downs J.R.
        • Weis S.E.
        • Miles J.S.
        • Gotto Jr, A.M.
        • Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators
        Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
        N Engl J Med. 2001; 344: 1959-1965
        • Elliott P.
        • Chambers J.C.
        • Zhang W.
        • Clarke R.
        • Hopewell J.C.
        • Peden J.F.
        • Erdmann J.
        • Braund P.
        • Engert J.C.
        • Bennett D.
        • Coin L.
        • Ashby D.
        • Tzoulaki I.
        • Brown I.J.
        • Mt-Isa S.
        • McCarthy M.I.
        • Peltonen L.
        • Freimer N.B.
        • Farrall M.
        • Ruokonen A.
        • Hamsten A.
        • Lim N.
        • Froguel P.
        • Waterworth D.M.
        • Vollenweider P.
        • Waeber G.
        • Jarvelin M.R.
        • Mooser V.
        • Scott J.
        • Hall A.S.
        • Schunkert H.
        • Anand S.S.
        • Collins R.
        • Samani N.J.
        • Watkins H.
        • Kooner J.S.
        Genetic loci associated with C-reactive protein levels and risk of coronary heart disease.
        JAMA. 2009; 302: 37-48
        • Pearson T.A.
        • Mensah G.A.
        • Alexander R.W.
        • Anderson J.L.
        • Cannon III, R.O.
        • Criqui M.
        • Fadl Y.Y.
        • Fortmann S.P.
        • Hong Y.
        • Myers G.L.
        • Rifai N.
        • Smith Jr, S.C.
        • Taubert K.
        • Tracy R.P.
        • Vinicor F.
        • Centers for Disease Control and Prevention; American Heart Association
        Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
        Circulation. 2003; 107: 499-511
        • Ridker P.M.
        • Paynter N.P.
        • Rifai N.
        • Gaziano J.M.
        • Cook N.R.
        C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men.
        Circulation. 2008; 118: 2243-2251
        • Ridker P.M.
        • Danielson E.
        • Fonseca F.A.
        • Genest J.
        • Gotto Jr, A.M.
        • Kastelein J.J.
        • Koenig W.
        • Libby P.
        • Lorenzatti A.J.
        • MacFadyen J.G.
        • Nordestgaard B.G.
        • Shepherd J.
        • Willerson J.T.
        • Glynn R.J.
        • JUPITER Study Group
        Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
        N Engl J Med. 2008; 359: 2195-2207
        • Rocha V.Z.
        • Libby P.
        Obesity, inflammation, and atherosclerosis.
        Nat Rev Cardiol. 2009; 6: 399-409
        • Weisberg S.P.
        • McCann D.
        • Desai M.
        • Rosenbaum M.
        • Leibel R.L.
        • Ferrante Jr, A.W.
        Obesity is associated with macrophage accumulation in adipose tissue.
        J Clin Invest. 2003; 112: 1796-1808
        • Hirosumi J.
        • Tuncman G.
        • Chang L.
        • Görgün C.Z.
        • Uysal K.T.
        • Maeda K.
        • Karin M.
        • Hotamisligil G.S.
        A central role for JNK in obesity and insulin resistance.
        Nature. 2002; 420: 333-336
        • Wang P.
        • Mariman E.
        • Renes J.
        • Keijer J.
        The secretory function of adipocytes in the physiology of white adipose tissue.
        J Cell Physiol. 2008; 216: 3-13
        • Steffes M.W.
        • Gross M.D.
        • Schreiner P.J.
        • Yu X.
        • Hilner J.E.
        • Gingerich R.
        • Jacobs Jr, D.R.
        Serum adiponectin in young adults—interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study.
        Ann Epidemiol. 2004; 14: 492-498
        • National Institutes of Health
        The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults (NIH Publication 00-4084).
        National Institutes of Health, Bethesda, Maryland2000
        • de Koning L.
        • Merchant A.T.
        • Pogue J.
        • Anand S.S.
        Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies.
        Eur Heart J. 2007; 28: 850-856
        • Visser M.
        • Bouter L.M.
        • McQuillan G.M.
        • Wener M.H.
        • Harris T.B.
        Elevated C-reactive protein levels in overweight and obese adults.
        JAMA. 1999; 282: 2131-2135
        • Hak A.E.
        • Stehouwer C.D.
        • Bots M.L.
        • Polderman K.H.
        • Schalkwijk C.G.
        • Westendorp I.C.
        • Hofman A.
        • Witteman J.C.
        Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women.
        Arterioscler Thromb Vasc Biol. 1999; 19: 1986-1991
        • Forouhi N.G.
        • Sattar N.
        • McKeigue P.M.
        Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians.
        Int J Obes Relat Metab Disord. 2001; 25: 1327-1331
        • Hu F.B.
        • Meigs J.B.
        • Li T.Y.
        • Rifai N.
        • Manson J.E.
        Inflammatory markers and risk of developing type 2 diabetes in women.
        Diabetes. 2004; 53: 693-700
        • Festa A.
        • D'Agostino Jr, R.
        • Williams K.
        • Karter A.J.
        • Mayer-Davis E.J.
        • Tracy R.P.
        • Haffner S.M.
        The relation of body fat mass and distribution to markers of chronic inflammation.
        Int J Obes Relat Metab Disord. 2001; 25: 1407-1415
        • Yudkin J.S.
        • Stehouwer C.D.
        • Emeis J.J.
        • Coppack S.W.
        C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?.
        Arterioscler Thromb Vasc Biol. 1999; 19: 972-978
        • Piché M.E.
        • Lemieux S.
        • Weisnagel S.J.
        • Corneau L.
        • Nadeau A.
        • Bergeron J.
        Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
        Am J Cardiol. 2005; 96: 92-97
        • Kahn S.E.
        • Zinman B.
        • Haffner S.M.
        • O'Neill M.C.
        • Kravitz B.G.
        • Yu D.
        • Freed M.I.
        • Herman W.H.
        • Holman R.R.
        • Jones N.P.
        • Lachin J.M.
        • Viberti G.C.
        Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
        Diabetes. 2006; 55: 2357-2364
        • Aronson D.
        • Bartha P.
        • Zinder O.
        • Kerner A.
        • Markiewicz W.
        • Avizohar O.
        • Brook G.J.
        • Levy Y.
        Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome.
        Int J Obes Relat Metab Disord. 2004; 28: 674-679
        • Santos A.C.
        • Lopes C.
        • Guimarães J.T.
        • Barros H.
        Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
        Int J Obes (Lond). 2005; 29: 1452-1456
        • Lemieux I.
        • Pascot A.
        • Prud'homme D.
        • Alméras N.
        • Bogaty P.
        • Nadeau A.
        • Bergeron J.
        • Després J.P.
        Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity.
        Arterioscler Thromb Vasc Biol. 2001; 21: 961-967
        • Kao T.W.
        • Lu I.S.
        • Liao K.C.
        • Lai H.Y.
        • Loh C.H.
        • Kuo H.K.
        Associations between body mass index and serum levels of C-reactive protein.
        S Afr Med J. 2009; 99: 326-330
        • Khaodhiar L.
        • Ling P.R.
        • Blackburn G.L.
        • Bistrian B.R.
        Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.
        J Parenter Enteral Nutr. 2004; 28: 410-415
        • Guldiken S.
        • Demir M.
        • Arikan E.
        • Turgut B.
        • Azcan S.
        • Gerenli M.
        • Tugrul A.
        The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein.
        Thromb Res. 2007; 119: 79-84
        • Pou K.M.
        • Massaro J.M.
        • Hoffmann U.
        • Vasan R.S.
        • Maurovich-Horvat P.
        • Larson M.G.
        • Keaney Jr, J.F.
        • Meigs J.B.
        • Lipinska I.
        • Kathiresan S.
        • Murabito J.M.
        • O'Donnell C.J.
        • Benjamin E.J.
        • Fox C.S.
        isceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.
        Circulation. 2007; 116: 1234-1241
        • Hamirani Y.S.
        • Pandey S.
        • Rivera J.J.
        • Ndumele C.
        • Budoff M.J.
        • Blumenthal R.S.
        • Nasir K.
        Markers of inflammation and coronary artery calcification: a systematic review.
        Atherosclerosis. 2008; 201: 1-7
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • Benjamin E.J.
        • Kupka M.J.
        • Manning W.J.
        • Clouse M.E.
        • D'Agostino R.B.
        • Wilson P.W.
        • O'Donnell C.J.
        C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.
        Circulation. 2002; 106: 1189-1191
        • Reilly M.P.
        • Wolfe M.L.
        • Rhodes T.
        • Girman C.
        • Mehta N.
        • Rader D.J.
        Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.
        Circulation. 2004; 110: 803-809
        • Williams M.J.
        • Williams S.M.
        • Milne B.J.
        • Hancox R.J.
        • Poulton R.
        Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults.
        Int J Obes Relat Metab Disord. 2004; 28: 998-1003
        • Lapice E.
        • Maione S.
        • Patti L.
        • Cipriano P.
        • Rivellese A.A.
        • Riccardi G.
        • Vaccaro O.
        Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people.
        Diabetes Care. 2009; 32: 1734-1736
        • Kim K.
        • Valentine R.J.
        • Shin Y.
        • Gong K.
        Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults.
        Metabolism. 2008; 57: 1181-1189
        • Campbell P.T.
        • Campbell K.L.
        • Wener M.H.
        • Wood B.L.
        • Potter J.D.
        • McTiernan A.
        • Ulrich C.M.
        A yearlong exercise intervention decreases CRP among obese postmenopausal women.
        Med Sci Sports Exerc. 2009; 41: 1533-1539
        • Habib P.
        • Scrocco J.D.
        • Terek M.
        • Vanek V.
        • Mikolich J.R.
        Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis.
        Am J Cardiol. 2009; 104: 1251-1255
        • Blaha M.
        • River
        • Budoff
        • Blumenthal R.
        Association between obesity, CRP≥2, and subclinical atherosclerosis—implications for the JUPITER trial: Multi-Ethnic Study of Atherosclerosis (MESA).
        Circulation. 2009; 120: s542
        • Dhaliwal S.S.
        • Welborn T.A.
        Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores.
        Am J Cardiol. 2009; 103: 1403-1407